Home / Drug shortages / Frovatriptan Succinate Tablet

Frovatriptan Succinate Tablet — FDA Drug Shortage

To Be Discontinued — Endo Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Frovatriptan Succinate Tablet (tablet) from Endo Pharmaceuticals, Inc. with status To Be Discontinued. The shortage was first posted on 11/12/2025.

Shortage Details

Status
To Be Discontinued
Company
Endo Pharmaceuticals, Inc.
Package NDC
0603-3718-34
Dosage Form
Tablet
Presentation
Frova, Tablet, 2.5 mg (NDC 0603-3718-34)
Initial Posting
11/12/2025
Revised Date

FDA data resources